Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
37.09
0.56 (1.53%)
At close: Aug 20, 2025, 9:48 AM

Tonix Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-130.04M -116.66M -110.22M -92.29M
Depreciation & Amortization
3.42M 4.29M 1.25M 50K
Stock-Based Compensation
4.78M 9.28M 10.91M 7.9M
Other Working Capital
4.79M 3.39M 1.04M 2.25M
Other Non-Cash Items
55.14M 1.12M 14.46M 3M
Deferred Income Tax
n/a n/a -14.46M n/a
Change in Working Capital
5.78M -35K -2K 5.78M
Operating Cash Flow
-60.92M -102M -98.05M -75.56M
Capital Expenditures
-120K -7.89M -48.15M -35.31M
Cash Acquisitions
n/a -22.17M n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 999K n/a n/a
Investing Cash Flow
-120K -29.07M -48.15M -35.31M
Debt Repayment
-2.35M 8.94M n/a n/a
Common Stock Repurchased
n/a -13.96M -47.25M n/a
Dividend Paid
n/a n/a -6.66M n/a
Other Financial Acitivies
-2.97M 41.54M 6.7M 98K
Financial Cash Flow
134.87M 36.52M 87.84M 212.49M
Net Cash Flow
73.83M -94.62M -58.43M 101.59M
Free Cash Flow
-61.05M -109.9M -146.2M -110.86M